Huons Amino Injection 3%

Adult dosage

Administer intravenously as a drip at a maximum dose of 1-1.5 g of total amino acids per day per kg of body weight. The infusion rate should ideally be about a concentration of 10 g of total amino acids over 60 minutes, with the principle of infusing 80-130 drops per minute.

Children's dosage

In pediatric patients, the dosage and infusion speed should be adjusted.

This medication must be used strictly according to a doctor's instructions, and one should not self-prescribe or adjust the dosage. It should not be administered to patients with hepatic coma or those at risk of hepatic coma, patients with severe kidney dysfunction, and those with certain metabolic disorders. Additionally, it is contraindicated in patients with congestive heart failure, pulmonary edema, oliguria, or anuria, and caution is needed for patients with hypernatremia or hyperkalemia. It is also prudent to avoid administration in patients allergic to ingredients contained in this medication or those with amino acid metabolism disorders. It must be used with caution in patients with severe acidosis, congestive heart failure, liver disorders, and kidney disorders, as there is a risk of allergic reactions or asthma attacks due to the presence of sulfites. During administration, allergic reactions such as rash, nausea, vomiting, palpitations, and increased blood pressure may occur, and immediate reporting to healthcare personnel is necessary if symptoms arise. Rapid or high-volume administration may lead to metabolic acidosis or other serious side effects, necessitating caution during use. Regular blood tests for blood glucose, electrolytes, liver, and kidney functions should be conducted to monitor the condition closely. Co-administration with certain drugs may reduce efficacy or cause side effects, so any other medications being taken must be communicated to healthcare personnel. Safety has not been established for pregnant women, and it should only be used when absolutely necessary. In children and elderly patients, dosage and administration speed must be adjusted with caution. This medication contains electrolytes and may cause electrolyte imbalance in cases of overdose, so it must be administered at a slow rate, and strict aseptic technique should be followed for preparation and management. During storage, avoid direct sunlight, and do not use solutions that show discoloration or abnormalities. It should be used promptly after opening.

Serious side effects

• Hives, severe swelling (edema), chest tightness, difficulty breathing, pallor, severe allergic reactions.
• Severe rashes, blisters, skin peeling, pain in the oral/eye mucosa, severe skin adverse reactions.
• Respiratory distress, asthma attacks, respiratory issues accompanied by cough and fever.
• Jaundice of the skin or eyes, generalized fatigue.
• Sudden and severe headaches, lightning-like headaches, seizures, confusion of consciousness, visual abnormalities, paralysis.
• Significant reduction in urine output, generalized issues.

Mild side effects

• Rash
• nausea
• vomiting
• chest discomfort
• palpitations
• tachycardia
• increased blood pressure
• chills
• fever
• headache

This medication should be stored in a sealed container to prevent exposure to air, and the storage temperature should be maintained between 1 and 30 degrees Celsius. By doing so, the medication's effectiveness will be preserved and degradation prevented.

Appearance

A transparent solution that is colorless or pale yellow, filled into a colorless and transparent polypropylene aqueous injection container.

Package unit

100 mL/bag, 250 mL/bag